GT200800206A - Dimeros de derivados de artemisinina, su preparacion y su aplicacion en terapeutica - Google Patents

Dimeros de derivados de artemisinina, su preparacion y su aplicacion en terapeutica

Info

Publication number
GT200800206A
GT200800206A GT200800206A GT200800206A GT200800206A GT 200800206 A GT200800206 A GT 200800206A GT 200800206 A GT200800206 A GT 200800206A GT 200800206 A GT200800206 A GT 200800206A GT 200800206 A GT200800206 A GT 200800206A
Authority
GT
Guatemala
Prior art keywords
dimeros
therapeutics
preparation
application
artemisinine
Prior art date
Application number
GT200800206A
Other languages
English (en)
Inventor
Alain Commercon
Jidong Zhang
Augustin Hittinger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200800206A publication Critical patent/GT200800206A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/04—Seven-membered rings not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/04—Seven-membered rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
    • C07D323/04—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings

Abstract

LA PRESENTE INVENCION SE REFIERE A DIMEROS DE DERIVADOS DE LA ARTEMISININA QUE PRESENTAN UNA ACTIVIDAD ANTICANCERIGENA Y EN PARTICULAR UNA ACTIVIDAD INHIBIDORA DE LA PROLIFERACION CELULAR EN LA QUE HASTA AHORA LA MAYORIA DE LOS COMPUESTOS COMERCIALES UTILIZADOS EN QUIMIOTERAPIA PLANTEAN PROBLEMAS IMPORTANTES DE EFECTOS SECUNDARIOS, DE TOLERANCIA POR LOS PACIENTES O TAMBIEN DE RESISTENCIA.
GT200800206A 2006-04-11 2008-10-08 Dimeros de derivados de artemisinina, su preparacion y su aplicacion en terapeutica GT200800206A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0603209A FR2899586B1 (fr) 2006-04-11 2006-04-11 Dimeres de derives d'artemisinine, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
GT200800206A true GT200800206A (es) 2008-12-04

Family

ID=37429238

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200800206A GT200800206A (es) 2006-04-11 2008-10-08 Dimeros de derivados de artemisinina, su preparacion y su aplicacion en terapeutica

Country Status (40)

Country Link
US (1) US8314142B2 (es)
EP (1) EP2007769B1 (es)
JP (1) JP5265518B2 (es)
KR (1) KR101357523B1 (es)
CN (1) CN101421276B (es)
AR (1) AR060400A1 (es)
AT (1) ATE512970T1 (es)
AU (1) AU2007235813B2 (es)
BR (1) BRPI0710152A2 (es)
CA (1) CA2641138C (es)
CR (1) CR10247A (es)
CY (1) CY1111833T1 (es)
DK (1) DK2007769T3 (es)
EA (1) EA015607B1 (es)
EC (1) ECSP088792A (es)
ES (1) ES2367715T3 (es)
FR (1) FR2899586B1 (es)
GT (1) GT200800206A (es)
HK (1) HK1131779A1 (es)
HN (1) HN2008001521A (es)
HR (1) HRP20110654T1 (es)
IL (1) IL194655A0 (es)
JO (1) JO2721B1 (es)
MA (1) MA30410B1 (es)
ME (1) ME00094B (es)
MX (1) MX2008012732A (es)
MY (1) MY154970A (es)
NO (1) NO20084352L (es)
NZ (1) NZ571342A (es)
PE (1) PE20080055A1 (es)
PL (1) PL2007769T3 (es)
PT (1) PT2007769E (es)
RS (1) RS51952B (es)
SI (1) SI2007769T1 (es)
TN (1) TNSN08321A1 (es)
TW (1) TWI423979B (es)
UA (1) UA94744C2 (es)
UY (1) UY30276A1 (es)
WO (1) WO2007116135A1 (es)
ZA (1) ZA200808025B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2925495B1 (fr) * 2007-12-21 2010-09-10 Pf Medicament Derives dimeriques d'artemisinine et application en therapie anticancereuse
FR2934593B1 (fr) * 2008-07-29 2010-09-10 Pf Medicament Derives dimeriques d'artemisinine et application en therapie anticancereuse
WO2011071981A2 (en) * 2009-12-08 2011-06-16 The Johns Hopkins University Anti-cytomegalovirus activity of artemisinin-derived dimers
US8815942B2 (en) 2010-10-20 2014-08-26 The Royal Institution For The Advancement Of Learning/Mcgill University Combination therapy and uses thereof for treatment and prevention of parasitic infection and disease
CN102010422B (zh) * 2010-11-23 2014-11-26 沈阳药科大学 含有胍基的青蒿素类衍生物及其应用
CN102614168A (zh) * 2011-01-31 2012-08-01 上海交通大学医学院附属瑞金医院 一种青蒿素衍生物及其药用盐的应用
WO2012111025A2 (en) * 2011-02-14 2012-08-23 Council Of Scientific & Industrial Research 1,2,3-triazole containing artemisinin compounds and process for preparation thereof
CN103570738B (zh) * 2012-08-07 2016-04-13 中国科学院上海生命科学研究院 新型青蒿素衍生物及其制法和应用
CN106928274B (zh) * 2017-02-28 2019-09-10 东南大学 一种双氢青蒿素二倍体衍生物、其药物组合物及应用
CN110240605B (zh) * 2018-03-08 2021-12-31 中国科学院上海药物研究所 青蒿素二聚物的制备方法
CN109467565B (zh) * 2018-08-16 2020-07-10 云白药征武科技(上海)有限公司 双氢青蒿素三聚体及其制备方法和应用
EP3911311A4 (en) * 2019-02-26 2023-01-25 Mahmoud A. Elsohly SELECTED ARTEMISININ DIMERS FOR THE TREATMENT OF LEISHMANIA
CN117285548A (zh) * 2022-06-16 2023-12-26 云南苏理生物医药科技有限公司 一种含硫类青蒿素二聚体、其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1084333C (zh) 1998-06-17 2002-05-08 中国科学院上海药物研究所 新的青蒿素化合物,其制备方法以及含有它们的药物组合物
FR2831538B1 (fr) * 2001-10-26 2004-01-16 Centre Nat Rech Scient Nouveaux derives de l'artemisinine, et leurs utilisations dans le traitement du paludisme
US6790863B2 (en) * 2002-10-15 2004-09-14 University Of Mississippi Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents
US7842720B2 (en) * 2004-06-21 2010-11-30 Elsohly Laboratories, Incorporated Anticancer and antiprotozoal dihydroartemisinene and dihydroartemisitene dimers with desirable chemical functionalities
CN101125142A (zh) 2007-07-24 2008-02-20 北京中医药大学东直门医院 青蒿素在制备抗肿瘤多药耐药药物中的应用

Also Published As

Publication number Publication date
ES2367715T3 (es) 2011-11-07
MA30410B1 (fr) 2009-05-04
ATE512970T1 (de) 2011-07-15
HK1131779A1 (en) 2010-02-05
CN101421276B (zh) 2012-11-14
FR2899586B1 (fr) 2008-06-20
MY154970A (en) 2015-08-28
SI2007769T1 (sl) 2011-10-28
AR060400A1 (es) 2008-06-11
AU2007235813A1 (en) 2007-10-18
KR20090009199A (ko) 2009-01-22
CY1111833T1 (el) 2015-10-07
BRPI0710152A2 (pt) 2011-08-02
MX2008012732A (es) 2008-10-17
WO2007116135A1 (fr) 2007-10-18
UY30276A1 (es) 2007-11-30
FR2899586A1 (fr) 2007-10-12
PT2007769E (pt) 2011-09-14
PE20080055A1 (es) 2008-03-24
ECSP088792A (es) 2008-11-27
UA94744C2 (ru) 2011-06-10
TWI423979B (zh) 2014-01-21
CA2641138C (fr) 2012-10-02
EA200870421A1 (ru) 2009-02-27
CR10247A (es) 2008-11-26
JP2009533398A (ja) 2009-09-17
TNSN08321A1 (en) 2009-12-29
TW200815456A (en) 2008-04-01
EP2007769A1 (fr) 2008-12-31
ME00094B (me) 2010-10-10
KR101357523B1 (ko) 2014-02-03
AU2007235813B2 (en) 2011-11-10
CA2641138A1 (fr) 2007-10-18
JP5265518B2 (ja) 2013-08-14
HN2008001521A (es) 2011-04-25
NO20084352L (no) 2008-10-16
HRP20110654T1 (hr) 2011-10-31
DK2007769T3 (da) 2011-10-03
EP2007769B1 (fr) 2011-06-15
IL194655A0 (en) 2009-08-03
JO2721B1 (en) 2013-09-15
US8314142B2 (en) 2012-11-20
MEP12308A (en) 2010-06-10
CN101421276A (zh) 2009-04-29
PL2007769T3 (pl) 2011-11-30
ZA200808025B (en) 2009-12-30
NZ571342A (en) 2011-01-28
US20090082426A1 (en) 2009-03-26
EA015607B1 (ru) 2011-10-31
RS51952B (en) 2012-02-29

Similar Documents

Publication Publication Date Title
GT200800206A (es) Dimeros de derivados de artemisinina, su preparacion y su aplicacion en terapeutica
CY1122522T1 (el) Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος
BRPI0922073A2 (pt) Compostos de éter com heterociclo de 5 membros contendo nitrogênio e usos dos mesmos.
BRPI0915084B8 (pt) composto, e, composição farmacêutica
CL2011000846A1 (es) Compuestos heterociclicos sustituidos; composicion farmaceutica; y su uso para el tratamiento de la hepatitis c.
BRPI0719008A2 (pt) Inibidores de vírus da hepatite c
HN2008000317A (es) Benzimidazoles sustituidos como inhibidores de cinasa
ECSP10010735A (es) Compuestos químicos 251
CL2013000304A1 (es) Compuestos derivados de 2-arilamino-bencimidazoles inhibidores de prostaglandina e2 (mpges-1); composicion farmaceutica que los comprende; compuestos intermediarios; uso en el tratamiento de enfermedades inflamatorias y/o afecciones asociadas, en particular el dolor.
DOP2010000304A (es) Composiciones y metodos de preparacion y uso de las mismas
BRPI0719797A2 (pt) compostos e composições como inibidores de proteína cinase
BRPI0815715A2 (pt) compostos 5-(-4-(haloalcóxi)fenil)pirimidina-2-amina e composições como inibidores de quinases.
HN2008001103A (es) Agentes citotoxicos que comprenden nuevos derivados de tomaimicina
DK2474321T3 (da) Sammensætninger til behandling af collagenmedierede sygdomme
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
EA201270308A1 (ru) Конъюгаты димеров пирроло [1,4]бензодиазепина в качестве противоракового средства
BRPI0718688A2 (pt) Composições de baixa irritação e métodos para preparar as mesmas.
CL2007002377A1 (es) Compuestos derivados de quinazolina; procedimiento de preparacion; composicion farmaceutica; y su uso como anticancerigeno.
BRPI0819299A2 (pt) Uso de composição, e, composição contendo proteína
CR9786A (es) Compuestos de bencimidazol-tiofeno
MX2010006206A (es) Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
BRPI0808172A2 (pt) Compostos heterocíclicos, composições compreendendo-os e métodos de seu uso.
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
BRPI0620985B1 (pt) composição farmacêutica, e usos de derivados de triazina e sensibilizadores de insulina
BRPI0916571A2 (pt) composto derivado de alquilaminometiloxazolidinona tricíclo, medicamento e composição farmacêutica que o contém e uso do composto